Til-Based Immunotherapy Products: Enhancing Cancer Treatment
Enhancing the body's immune response to fight against cancer has been a critical area of focus in the field of oncology. Beijing BIOOCUS Biotech Ltd. has developed a cutting-edge Til-Based Immunotherapy Product that has shown promising results in boosting the body's natural defense mechanisms against cancer cells, By utilizing Tumor Infiltrating Lymphocytes (TILs), our innovative immunotherapy product aims to harness the power of the immune system to target and destroy cancer cells. This personalized approach involves isolating TILs from a patient's tumor, expanding their numbers in the laboratory, and then infusing them back into the patient to identify and eradicate cancer cells
- High-Quality B-Cell Lymphoma
- Best B-Cell Lymphoma
- China B-Cell Non-Hodgkin Lymphoma
- High-Quality B-Cell Non-Hodgkin Lymphoma
- Best B-Cell Non-Hodgkin Lymphoma
- China B-Cell Leukemia
- High-Quality B-Cell Leukemia
- Best B-Cell Leukemia
- China B-Cell All (Acute Lymphoblastic Leukemia)
- High-Quality B-Cell All (Acute Lymphoblastic Leukemia)